| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/11/2004 | EP1445259A1 Process and crystal forms of 2-methyl-thieno-benzodiazepine |
| 08/11/2004 | EP1445258A1 Activator for peroxisome proliferator-activated receptor delta |
| 08/11/2004 | EP1445256A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient |
| 08/11/2004 | EP1445252A1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 08/11/2004 | EP1444985A2 Use of follistatin for the manufacture of a medicament for the treatment of a non-degenerative nervous system disorder |
| 08/11/2004 | EP1444981A1 Intracellular calcium concentration increase inhibitors |
| 08/11/2004 | EP1444979A1 Pharmaceutical compositions comprising an NMDA receptor agonist or partial agonist for the treatment of movement disorders |
| 08/11/2004 | EP1444520A2 Methods for monitoring amyotrophic lateral sclerosis |
| 08/11/2004 | EP1444330A1 Expansion of t cells in vitro and expanded t cell populations |
| 08/11/2004 | EP1444265A2 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 08/11/2004 | EP1444254A2 Molecules for disease detection and treatment |
| 08/11/2004 | EP1444251A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 08/11/2004 | EP1444233A2 A 2b? adenosine receptor antagonists |
| 08/11/2004 | EP1444232A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase |
| 08/11/2004 | EP1444229A1 Pyrazole derivatives as psychopharmaceuticals |
| 08/11/2004 | EP1444228A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 08/11/2004 | EP1444227A1 Thiazolyl substituted triazoles as alk5 inhibitors |
| 08/11/2004 | EP1444226A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 08/11/2004 | EP1444219A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor |
| 08/11/2004 | EP1444215A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/11/2004 | EP1444212A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds |
| 08/11/2004 | EP1444207A2 Substituted pyrazolyl-compounds for the treatment of inflammation |
| 08/11/2004 | EP1444206A1 Substituted benzo b azepin-2-one compounds |
| 08/11/2004 | EP1444203A1 Cannabinoid receptor ligands |
| 08/11/2004 | EP1444202A1 Novel metalloproteinase inhibitors |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1444200A1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 08/11/2004 | EP1443986A2 Drug delivery system for conscious sedation |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443960A2 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 08/11/2004 | EP1443958A2 Vaccine against infectious disease |
| 08/11/2004 | EP1443956A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 08/11/2004 | EP1443955A1 Treatment of central nervous system disorders by use of pdgf or vegf |
| 08/11/2004 | EP1443947A1 Use of defibrinated blood for the manufacture of a hemoglobin-based oxygen carrier |
| 08/11/2004 | EP1443943A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 08/11/2004 | EP1443941A2 Agents for treating lesions of the nervous system |
| 08/11/2004 | EP1443939A1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 08/11/2004 | EP1443937A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443932A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 08/11/2004 | EP1443929A2 Treatment of cns disorders using cns target modulators |
| 08/11/2004 | EP1443928A2 Treatment of neurodegenerative diseases and cancer of the brain |
| 08/11/2004 | EP1443926A1 Pyridine derivatives as nmda-receptor subtype blockers |
| 08/11/2004 | EP1443925A1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 08/11/2004 | EP1443923A1 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 08/11/2004 | EP1443920A2 Preparation for improving the action of receptors |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443816A2 Methods of treating disorders related to apoe |
| 08/11/2004 | EP1358182B1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | EP1135381B1 Eletriptan hydrobromide monohydrate |
| 08/11/2004 | EP1109813B1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/11/2004 | EP1107965B1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application |
| 08/11/2004 | EP1014974B1 Treatment of schizophrenia and psychosis |
| 08/11/2004 | EP0977859B1 The neurotrophic factor nnt-1 |
| 08/11/2004 | EP0937047B1 1-arylphthalazine antagonists of excitatory amino acid receptors |
| 08/11/2004 | EP0934308B1 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 08/11/2004 | EP0877744B1 Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 08/11/2004 | CN1520424A Immunoglobulins 2 |
| 08/11/2004 | CN1520416A 碳水化合物衍生物 Carbohydrate derivatives |
| 08/11/2004 | CN1520414A Novel compound, its prepn. and application |
| 08/11/2004 | CN1520410A Novel heteroaryl derivatives, their prepn. and use |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520405A Process for prepn. of racemic citalopram and/or S-or R-citalopram by separation of mixture of R-and S-citalopram |
| 08/11/2004 | CN1520404A Piperazinylpyrazines compounds as antagonists of serotonin-5-HT2 receptor |
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520309A Methods and compsns. for treating oral and eosophagal lesions |
| 08/11/2004 | CN1520305A Compsns. for preparing external carbon dioxide agents |
| 08/11/2004 | CN1520299A Use of compounds with combined NEP/MP-inbihitory activity in prepan. of medicaments |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1520290A Carbocyclic hydrorazino inhibitors of copper-containing amine oxidases |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
| 08/11/2004 | CN1519239A Ramification of a compound of medication as well as preparation method and application |
| 08/11/2004 | CN1519005A Prepared Chinese medicine for treating insomnia and preparaton method |
| 08/11/2004 | CN1518995A Medication for anti senile dementia as well as preparation method usage |
| 08/11/2004 | CN1518992A Application of 'Qingkailing' in preparing medication for treating diseases in nerve and immunity |
| 08/11/2004 | CN1161356C Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' |
| 08/11/2004 | CN1161338C Fluorinated 3,4-dihydroquinoline derivatives used and NOS inhibitors |
| 08/11/2004 | CN1161146C Chinese medicine for treating coronary heart disease, reducing blood fat and improving sleep and its preparing process |
| 08/11/2004 | CN1161145C Chinese medicine for treatment of depression |
| 08/11/2004 | CN1161140C Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| 08/11/2004 | CN1161122C Novel Composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods |
| 08/11/2004 | CN1161118C Use of 5HT3 receptor antagouists for the treatment of chronic fatigue syndrome |
| 08/11/2004 | CN1161114C Usage of compound in pharmaceutic mfg. for treating sleep apnoea |
| 08/11/2004 | CN1161110C Oral delayed immediate release formulation and method of preparation therefor |
| 08/11/2004 | CN1161109C Fluoxetine enteric micropills |
| 08/10/2004 | US6774241 Ht3 receptor antagonists for nervous system, psychological, eating, and sleep disorder treatment |
| 08/10/2004 | US6774230 Such as 1-(3-carboxypyridyl-2)-4-methyl-2- phenylpiperazine dihydrate; antidepressants |
| 08/10/2004 | US6774136 Substituted 1 and 2 naphthol mannich bases |
| 08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
| 08/10/2004 | US6774131 Prostate cancer |
| 08/10/2004 | US6774129 Alpha 2-adrenoceptor antagonists; antidepressants and treating parkinson's disease |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6773891 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. these conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. the novel conjugates preserve the chirality of nicotine in |
| 08/10/2004 | US6773729 Administering combination of ginseng and ginkgo to improve the speed of memory and memory quality in normal, healthy subjects and to prevent deterioration of the speed of memory in people with decreased cognitive functions |
| 08/10/2004 | US6773724 Improved solubility |